Typical PA requirements include: Confirmed diagnosis of type 2 diabetes or obesity Documented BMI (often 30 or 27 with comorbidities) Failed trials of other medications Lifestyle modification attempts Recent A1C lab values (for diabetes) Documentation Must Include Height and weight with calculated BMI Diagnosis supporting medical necessity Treatment plan Follow-up and monitoring plan Compliance & Audit Risk GLP-1 medications are a high-risk audit target due to: Rapid growth in utilization High drug cost Off-label prescribing Weight-loss demand Common audit issues: Incorrect diagnosis codes Missing BMI documentation Lack of medical necessity Billing weight-loss drugs to Medicare Inappropriate use of unclassified J-codes Medicare Coverage Rules Medicare Part D generally does not cover weight-loss drugs , even if FDA-approved for obesity
Instead, keep a hydrating lip balm handy to reapply throughout the day
This is what evidence-based ECS science looks like: rigorous mechanistic validation, clinical relevance, decades of safety precedent, and therapeutic rationale independent of phytocannabinoid delivery
Never increase, decrease, delay, or skip doses without discussing your treatment plan with the licensed healthcare professional managing your care
But there are some things to think about before adding berberine to your daily routine: Advertisement Also, while berberine is safe for adults, if youre pregnant or breastfeeding, you shouldnt take berberine
Neuropsychopharmacology 37:338349 Summer GJ, Romero-Sandoval EA, Bogen O, Dina OA, Khasar SG, Levine JD (2008) Proinflammatory cytokines mediating burn-injury pain